Streetbeat News

Equity Actions

SABR

Sabre Corporation (NASDAQ:SABR), a global travel technology provider, announced Gail Mandel as the new non-executive Chair of the Board, effective at the 2024 Annual Meeting on April 24. Mandel, a former Wyndham Worldwide executive and current Sabre Board member since April 2020, will succeed Sean Menke, who is retiring. Mandel's leadership aims to drive Sabre's strategic transformation, focusing on innovation and sustainable growth. Menke, having served since 2016, is credited with leading Sabre through significant challenges and technological advancements.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:17 pm

QNRX

Quoin Pharmaceuticals announced the pricing of a $6.5 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:09 pm

SMRT

SmartRent has announced a new stock repurchase program valued at $50 million, signaling confidence in the company's future prospects and potentially increasing shareholder value.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:02 pm

CASY

Casey's General Stores (NASDAQ:CASY) has received mixed analyst ratings over the past three months, with an average 12-month price target of $315.6, indicating a 5.08% increase from the previous target. Analysts from Wells Fargo, Benchmark, Stephens & Co., RBC Capital, and BMO Capital have provided updates, with most raising their price targets. The company's financial performance shows positive revenue growth, a strong net margin, and effective debt management, positioning it well in the market.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 1:02 pm

ANSS

Analyst ratings for Ansys (NASDAQ:ANSS) have shown a mix of neutrality and slight bearishness over the last quarter, with a recent shift towards a more neutral stance in the last 30 days. The average 12-month price target for ANSS has been raised to $340.0, indicating a 2.41% increase from the previous target. Ansys's financial performance showcases strong revenue growth and net margin, but a below-average Return on Equity (ROE).

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 1:02 pm

QNRX

Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) announced a public offering priced at $6.5M, involving 4,062,500 ordinary shares represented by American Depositary Shares and Series D and E warrants. The offering, managed by A.G.P./Alliance Global Partners as the sole placement agent, aims to raise funds for general corporate purposes, with a closing date expected around March 7, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:02 pm

MNTS

Momentus Inc. (NASDAQ:MNTS) announced a registered direct offering of 4,624,280 shares at $0.865 per share, aiming to raise approximately $4.0 million. The offering includes warrants with an exercise price of $0.74, exercisable immediately and expiring in five years. A.G.P./Alliance Global Partners is the placement agent for this offering, which is expected to close by March 7, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:00 pm

ALB

Albemarle Corporation's stock is trading lower following the announcement of a proposed public offering of depositary shares. This move could potentially dilute existing shareholders' equity, leading to the decrease in stock price.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 12:17 pm

NDAQ

Nasdaq has outlined its strategy for growth and reaffirmed its medium-term outlook, focusing on achieving synergy and deleveraging targets from the Adenza integration. The company aims to realize 70% of its targeted $80 million in net expense synergies ahead of schedule by the end of 2024. Additionally, Nasdaq plans to accelerate its deleveraging process, intending to reach a 4.0x leverage ratio 9-12 months earlier and a 3.3x leverage ratio at least 6 months before its previously announced targets.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 12:03 pm

IRM

Analysts have recently updated their evaluations and price targets for Iron Mountain (NYSE:IRM), showing a positive shift in sentiment. The average 12-month price target has been raised to $81.5, marking a 13.19% increase from the previous target of $72.00. This adjustment reflects analysts' reactions to market conditions and Iron Mountain's performance, with recent ratings ranging from 'Overweight' to 'Buy'. Iron Mountain, a REIT specializing in record management services, has shown notable financial performance including an 11.01% revenue growth and a 12.01% ROE, despite a high debt-to-equity ratio of 69.87.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 12:00 pm